Keyphrases
Cutaneous T-cell Lymphoma
50%
Malignant T Cells
49%
T Cells
49%
Thymus
30%
Lesional Skin
26%
Thymocytes
25%
Natural Killer Cells
18%
Nonmalignant
17%
T Cell Development
16%
Dysregulation
16%
T Cell Lineage
16%
Kv1.3
15%
CD4+ T Cells
15%
Gene-deficient Mice
15%
Dermatitis
15%
Voltage-gated Potassium Channel Kv1.3
15%
Interleukin-12 (IL-12)
15%
Filaggrin
15%
STAT3 Signaling
15%
Disease Activity
15%
Antibiotics
15%
Cellular Heterogeneity
15%
Metastable Intermediates
15%
Inhibit Tumor
15%
Developmental Pathways
15%
Infiltration
15%
Inducible T-cell Co-stimulator
15%
Interleukin-18 (IL-18)
15%
Sorting Motif
15%
T-cell Lymphoma
15%
STAT3 Activation
15%
Tumor Activity
15%
Gut Inflammation
15%
T Cell Subsets
15%
Leucine
15%
Interleukin-17 (IL-17)
15%
Immunology and Microbiology
T Cell
100%
T Cell Receptor
40%
Thymus
30%
Thymocyte
27%
CD3 Antigen
22%
Cytokine
18%
Lineage
18%
Cell Lineage
15%
T-Helper Cell
15%
Cell Heterogeneity
15%
Tumor Necrosis Factor
15%
Natural Killer Cell
15%
Leucine
15%
Interleukin 17
15%
T Cell Development
15%
Medicine and Dentistry
T Cell
47%
Potassium Channel Kv1.3
30%
Cutaneous T Cell Lymphoma
22%
Natural Killer Cell Lymphoma
15%
Cell Line
15%
Dermatitis
15%
Inducible T Cell Costimulator
15%
T-Cell Lymphoma
15%
